Carregant...
Enzyme Polymorphism in Warfarin Dose Management After Pediatric Cardiac Surgery
BACKGROUND: Warfarin is an anticoagulant and is widely used for the prevention of thromboembolic events. Genetic variants of the enzymes that metabolize warfarin, i.e. cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1), contribute to differences in patients’ responses to various w...
Guardat en:
| Publicat a: | Res Cardiovasc Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Kowsar
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592525/ https://ncbi.nlm.nih.gov/pubmed/26448196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/cardiovascmed.27963v2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|